CN107937296B - Recombinant saccharomyces cerevisiae with acetic acid, furfural and vanillin tolerance, and preparation method and application thereof - Google Patents
Recombinant saccharomyces cerevisiae with acetic acid, furfural and vanillin tolerance, and preparation method and application thereof Download PDFInfo
- Publication number
- CN107937296B CN107937296B CN201711229127.0A CN201711229127A CN107937296B CN 107937296 B CN107937296 B CN 107937296B CN 201711229127 A CN201711229127 A CN 201711229127A CN 107937296 B CN107937296 B CN 107937296B
- Authority
- CN
- China
- Prior art keywords
- saccharomyces cerevisiae
- ypl162c
- furfural
- strain
- gene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 title claims abstract description 78
- 240000004808 Saccharomyces cerevisiae Species 0.000 title claims abstract description 72
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 title claims abstract description 72
- HYBBIBNJHNGZAN-UHFFFAOYSA-N furfural Chemical compound O=CC1=CC=CO1 HYBBIBNJHNGZAN-UHFFFAOYSA-N 0.000 title claims abstract description 52
- MWOOGOJBHIARFG-UHFFFAOYSA-N vanillin Chemical compound COC1=CC(C=O)=CC=C1O MWOOGOJBHIARFG-UHFFFAOYSA-N 0.000 title claims abstract description 28
- 235000012141 vanillin Nutrition 0.000 title claims abstract description 28
- FGQOOHJZONJGDT-UHFFFAOYSA-N vanillin Natural products COC1=CC(O)=CC(C=O)=C1 FGQOOHJZONJGDT-UHFFFAOYSA-N 0.000 title claims abstract description 28
- 238000002360 preparation method Methods 0.000 title abstract description 6
- 101150009618 YPL162C gene Proteins 0.000 claims abstract description 22
- 238000004321 preservation Methods 0.000 claims abstract description 6
- 238000009629 microbiological culture Methods 0.000 claims abstract description 3
- 244000005700 microbiome Species 0.000 claims abstract 2
- 239000012634 fragment Substances 0.000 claims description 17
- 108090000623 proteins and genes Proteins 0.000 claims description 16
- 238000006243 chemical reaction Methods 0.000 claims description 12
- 238000000034 method Methods 0.000 claims description 12
- 230000014509 gene expression Effects 0.000 claims description 11
- 239000013612 plasmid Substances 0.000 claims description 11
- 239000003112 inhibitor Substances 0.000 claims description 9
- 230000010354 integration Effects 0.000 claims description 9
- 239000013598 vector Substances 0.000 claims description 8
- 238000001976 enzyme digestion Methods 0.000 claims description 5
- 239000013604 expression vector Substances 0.000 claims description 5
- 244000253724 Saccharomyces cerevisiae S288c Species 0.000 claims description 4
- 235000004905 Saccharomyces cerevisiae S288c Nutrition 0.000 claims description 4
- 230000009466 transformation Effects 0.000 claims description 4
- 238000012408 PCR amplification Methods 0.000 claims description 3
- 238000010276 construction Methods 0.000 claims description 2
- 241000620209 Escherichia coli DH5[alpha] Species 0.000 claims 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract description 90
- 238000000855 fermentation Methods 0.000 abstract description 29
- 230000004151 fermentation Effects 0.000 abstract description 29
- 230000012010 growth Effects 0.000 abstract description 21
- 241000894006 Bacteria Species 0.000 abstract description 8
- 230000006353 environmental stress Effects 0.000 abstract description 3
- 241000233866 Fungi Species 0.000 abstract description 2
- 230000006799 invasive growth in response to glucose limitation Effects 0.000 abstract description 2
- CKOYRRWBOKMNRG-UHFFFAOYSA-N Furfuryl acetate Chemical compound CC(=O)OCC1=CC=CO1 CKOYRRWBOKMNRG-UHFFFAOYSA-N 0.000 abstract 2
- 235000019441 ethanol Nutrition 0.000 description 29
- 210000004027 cell Anatomy 0.000 description 27
- 239000007788 liquid Substances 0.000 description 21
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 18
- 239000008103 glucose Substances 0.000 description 18
- 239000006228 supernatant Substances 0.000 description 17
- 230000001580 bacterial effect Effects 0.000 description 16
- 239000001963 growth medium Substances 0.000 description 15
- 230000002018 overexpression Effects 0.000 description 12
- 238000012258 culturing Methods 0.000 description 11
- 108020004414 DNA Proteins 0.000 description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- 101100106690 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) YPL162C gene Proteins 0.000 description 9
- BRZYSWJRSDMWLG-CAXSIQPQSA-N geneticin Chemical compound O1C[C@@](O)(C)[C@H](NC)[C@@H](O)[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](C(C)O)O2)N)[C@@H](N)C[C@H]1N BRZYSWJRSDMWLG-CAXSIQPQSA-N 0.000 description 8
- 238000011218 seed culture Methods 0.000 description 8
- 239000000243 solution Substances 0.000 description 8
- 239000001888 Peptone Substances 0.000 description 7
- 108010080698 Peptones Proteins 0.000 description 7
- 229940041514 candida albicans extract Drugs 0.000 description 7
- 235000019319 peptone Nutrition 0.000 description 7
- 239000000843 powder Substances 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- 239000012138 yeast extract Substances 0.000 description 7
- 101000579123 Homo sapiens Phosphoglycerate kinase 1 Proteins 0.000 description 6
- 102100028251 Phosphoglycerate kinase 1 Human genes 0.000 description 6
- 239000002609 medium Substances 0.000 description 6
- KJWZYMMLVHIVSU-IYCNHOCDSA-N PGK1 Chemical compound CCCCC[C@H](O)\C=C\[C@@H]1[C@@H](CCCCCCC(O)=O)C(=O)CC1=O KJWZYMMLVHIVSU-IYCNHOCDSA-N 0.000 description 5
- 238000002156 mixing Methods 0.000 description 5
- 238000010790 dilution Methods 0.000 description 4
- 239000012895 dilution Substances 0.000 description 4
- 230000031700 light absorption Effects 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 241000588724 Escherichia coli Species 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 239000012880 LB liquid culture medium Substances 0.000 description 3
- 238000000246 agarose gel electrophoresis Methods 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 238000007710 freezing Methods 0.000 description 3
- 230000008014 freezing Effects 0.000 description 3
- 239000000446 fuel Substances 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 238000012216 screening Methods 0.000 description 3
- 230000035882 stress Effects 0.000 description 3
- 238000012795 verification Methods 0.000 description 3
- 210000005253 yeast cell Anatomy 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 238000007400 DNA extraction Methods 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 101150043522 HO gene Proteins 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 241001052560 Thallis Species 0.000 description 2
- 230000003698 anagen phase Effects 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 239000001110 calcium chloride Substances 0.000 description 2
- 229910001628 calcium chloride Inorganic materials 0.000 description 2
- 230000010261 cell growth Effects 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 238000010353 genetic engineering Methods 0.000 description 2
- 239000002054 inoculum Substances 0.000 description 2
- PHTQWCKDNZKARW-UHFFFAOYSA-N isoamylol Chemical compound CC(C)CCO PHTQWCKDNZKARW-UHFFFAOYSA-N 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000036542 oxidative stress Effects 0.000 description 2
- 239000008188 pellet Substances 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 108091008146 restriction endonucleases Proteins 0.000 description 2
- 238000005070 sampling Methods 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 239000007222 ypd medium Substances 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 1
- 241000972773 Aulopiformes Species 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 108091092584 GDNA Proteins 0.000 description 1
- 108700007698 Genetic Terminator Regions Proteins 0.000 description 1
- 125000002288 PGK1 group Chemical group 0.000 description 1
- 108020002230 Pancreatic Ribonuclease Proteins 0.000 description 1
- 102000005891 Pancreatic ribonuclease Human genes 0.000 description 1
- 238000010802 RNA extraction kit Methods 0.000 description 1
- 239000007984 Tris EDTA buffer Substances 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 229920004890 Triton X-100 Polymers 0.000 description 1
- 239000013504 Triton X-100 Substances 0.000 description 1
- 101710100170 Unknown protein Proteins 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 238000007605 air drying Methods 0.000 description 1
- 229960000723 ampicillin Drugs 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 150000001491 aromatic compounds Chemical class 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000002551 biofuel Substances 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 230000022131 cell cycle Effects 0.000 description 1
- 230000005779 cell damage Effects 0.000 description 1
- 208000037887 cell injury Diseases 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 210000000349 chromosome Anatomy 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 150000002240 furans Chemical class 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 230000006801 homologous recombination Effects 0.000 description 1
- 238000002744 homologous recombination Methods 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- XIXADJRWDQXREU-UHFFFAOYSA-M lithium acetate Chemical compound [Li+].CC([O-])=O XIXADJRWDQXREU-UHFFFAOYSA-M 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 238000000386 microscopy Methods 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 230000001376 precipitating effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000003753 real-time PCR Methods 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 235000019515 salmon Nutrition 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 229910021642 ultra pure water Inorganic materials 0.000 description 1
- 239000012498 ultrapure water Substances 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/37—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
- C07K14/39—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts
- C07K14/395—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts from Saccharomyces
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/14—Fungi; Culture media therefor
- C12N1/16—Yeasts; Culture media therefor
- C12N1/18—Baker's yeast; Brewer's yeast
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/36—Adaptation or attenuation of cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
- C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Cell Biology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Botany (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
The invention relates to the technical field of microorganism biology, in particular to recombinant saccharomyces cerevisiae with furfural acetate vanillin tolerance, a preparation method and application thereof. The main technical scheme is as follows: a recombinant Saccharomyces cerevisiae with furfural acetate vanillin tolerance is named as S288C-YPL162C, the preservation number of the strain is CGMCC No.13925, the strain is preserved in the China general microbiological culture Collection center, and the preservation date is 2017, 03 and 23 days; the strain carries YPL162C gene, and the GenBank accession number of YPL162C gene is NM-001183976.1. The saccharomyces cerevisiae strain is unicellular fungus, and the shape of the saccharomyces cerevisiae strain is mostly oval and round. The colony morphology is similar to that of bacteria, but is larger and thicker, and is milky white, and the surface is wet and sticky. The saccharomyces cerevisiae S288C-YPL162C disclosed by the invention has good growth and ethanol fermentation performances under the environmental stress conditions of respectively containing high-concentration acetic acid, furfural, vanillin and the like.
Description
Technical Field
The invention belongs to the technical field of microbial biology, and particularly relates to recombinant saccharomyces cerevisiae with acetic acid, furfural and vanillin tolerance, and a preparation method and application thereof.
Background
With the rapid development of economy, the problem of energy shortage is highlighted, and fuel ethanol is widely concerned as a clean renewable energy source. As a big agricultural country, the lignocellulose is rich in source, low in price and renewable. Therefore, the development of the method for producing the fuel ethanol by using the agricultural and forestry waste lignocellulose as the raw material has important significance. The lignocellulose is used as a substrate for producing fuel ethanol, firstly, the lignocellulose needs to be subjected to acid-base pretreatment, a large amount of toxic byproducts such as organic acids, furans, aromatic compounds and the like are generated in the process (Biotechnology for Biofuels, 2013, 6 (1): 1-10), and the normal operation of yeast ethanol fermentation is seriously influenced by inhibiting the yeast growth and ethanol production through interfering the cell membrane composition, influencing the intracellular enzyme activity and the like.
The research shows that the protein coded by YPL162C gene is located on the vacuolar membrane, the specific function is unknown, and the function is related to the cell cycle morphology (Genome Biology, 2010, 11: R24). Simultaneously participate in Zn2+Transport (Journal of Cell Biology, 2015, 211: 639-. Expression of YPL162C gene was up-regulated when Saccharomyces cerevisiae W303-1A was faced with oxidative stress, and it was possible that the protein encoded by YPL162C gene was involved in repair of Cell damage after oxidative stress (Molecular Biology of the Cell, 2006, 17: 1472-1482). However, the gene has less research on the tolerance of acetic acid, furfural and vanillin, and no report that the tolerance of acetic acid, furfural and vanillin can be improved by over-expression of the gene is found at present.
Disclosure of Invention
In order to make up the defects of the prior art, the invention provides the recombinant saccharomyces cerevisiae with acetic acid, furfural and vanillin tolerance, and the preparation method and application thereof.
The technical scheme of the invention is as follows: a recombinant Saccharomyces cerevisiae S288C-YPL162C (Saccharomyces cerevisiae) with acetic acid, furfural and vanillin tolerance is disclosed, the preservation number of the strain is CGMCC No.13925, the strain is preserved in the China general microbiological culture Collection center, and the preservation date is 2017, 03 and 23 days; the strain carries YPL162C gene, and the GenBank accession number of YPL162C gene is NM-001183976.1. The saccharomyces cerevisiae strain is unicellular fungus, and the shape of the saccharomyces cerevisiae strain is mostly oval and round. The colony morphology is similar to that of bacteria, but is larger and thicker, and is milky white, and the surface is wet and sticky. The nutrition mode is heterotrophic facultative anaerobic type. The product is free and milky white when growing in the culture medium.
The GenBank accession number of the PGK1 promoter sequence is FJ415226.1, and the GenBank accession number of the CYC1 terminator sequence is EF 210198.1. A pHO constitutive expression vector is formed by connecting a PGK1 strong promoter and a CYC1 terminator on the basis of an pHO integration vector (NCBI: # AF324728, David J.Stillman benefit of Utah university, USA; Nucleic acids research, 2001, 29: e59) of yeast through a genetic engineering means. Earlier studies showed that self-flocculating yeast SPSC01 and free yeast SPSC01△FLO1Compared with the resistance to environmental stress, the YPL162C gene is obtained by PCR amplification by using a self-flocculating yeast SPSC01 genome as a template and is connected between a PGK1 promoter and a CYC1 terminator. After linearization, the DNA was introduced into Saccharomyces cerevisiae S288C by chemical transformation method for overexpression (Nature Protocols, 2007, 2(1): 31-35). The introduced target fragment is integrated and expressed at the HO gene site of the Saccharomyces cerevisiae genome (Yeast, 1997, 13: 1563-1573).
The invention adopts pHO constitutive expression vector of saccharomyces cerevisiae to carry out integration expression of recombinant strain, pHO constitutive expression vector can carry out integration expression at HO gene site of saccharomyces cerevisiae in a homologous recombination mode, the vector inserts PGK1 promoter and CYC1 terminator at the multiple cloning site of plasmid by a genetic engineering means to obtain constitutive integration expression vector, and screening is carried out according to the geneticin G418 resistance contained in the vector (screening is carried out on a plate containing G418, only an individual successfully introduced with a target fragment containing G418 gene can grow on the plate).
The invention also claims the application of the saccharomyces cerevisiae S288C-YPL162C under the condition of inhibitor stress, such as good growth under the condition of high concentration of acetic acid, furfural or vanillin and higher ethanol fermentation efficiency compared with the control strain S288C-HO.
The invention has the following beneficial effects: (1) the invention provides a novel strain; (2) the recombinant saccharomyces cerevisiae S288C-YPL162C can grow well and ferment ethanol under the environmental stress conditions of respectively containing high-concentration acetic acid, furfural, vanillin and the like.
Drawings
FIG. 1 PCR amplification of YPL162C gene fragment;
FIG. 2 YPL162C vector;
FIG. 3 PCR identification of positive transformants;
FIG. 4 is a comparison of expression levels of YPL162C gene in recombinant Saccharomyces cerevisiae S288C-YPL162C and recombinant Saccharomyces cerevisiae S288C-HO control strain;
FIG. 5 microscopic examination of recombinant unloaded yeast S288C-HO control strain and recombinant Saccharomyces cerevisiae S288C-YPL 162C;
wherein: (a) S288C-HO, (b) S288C-YPL 162C.
FIG. 6 comparison of the growth of recombinant unloaded yeast S288C-HO control strain and recombinant Saccharomyces cerevisiae S288C-YPL162C in plates containing different inhibitors;
wherein: (a) growth of the over-expressing strain and the control strain without addition of inhibitor; (b) the growth conditions of the over-expression strain and the control strain under the addition of 10g/L acetic acid; (c) the growth conditions of the over-expression strain and the control strain under the condition of adding 1g/L of vanillin; (d) growth of the over-expression strain and the control strain with 1.5g/L furfural addition.
FIG. 7 recombinant unloaded yeast S288C-HO control strain and recombinant Saccharomyces cerevisiae S288C-YPL162C ethanol fermentation with 10g/L acetic acid addition;
wherein: (a) growth of the over-expressing strain and the control strain with the addition of 10g/L acetic acid as a function of time; (b) the ethanol concentration and the residual glucose in the fermentation liquid changed with time under the addition of 10g/L acetic acid.
FIG. 8 recombinant unloaded yeast S288C-HO control strain and recombinant Saccharomyces cerevisiae S288C-YPL162C ethanol fermentation with 2g/L vanillin addition;
wherein: (a) growth of the over-expressing strain and the control strain with the addition of 2g/L vanillin as a function of time; (b) the ethanol concentration and the residual glucose in the fermentation liquid change with time under the addition of 2g/L vanillin.
FIG. 9 recombinant unloaded yeast S288C-HO control strain and recombinant Saccharomyces cerevisiae S288C-YPL162C ethanol fermentation with 3g/L furfural addition;
wherein: (a) the growth of the over-expression strain and the control strain changes along with time under the condition of 3g/L furfural addition; (b) the change of the ethanol concentration and the residual glucose in the fermentation liquid with the addition of 3g/L furfural along with the time.
Detailed Description
Example 1: construction and transformation of recombinant Saccharomyces cerevisiae of unknown functional protein gene YPL162C
The YPL162C gene is obtained from NCBI public database, and the GenBank accession number of YPL162C gene is NM-001183976.1. The promoter of the gene is PGK1 promoter, CYC1 terminator is used as terminator, and YPL162C gene is inserted between PGK1 promoter and CYC1 terminator by enzyme digestion connection. The constructed plasmid is then cut linearly by restriction endonuclease Not I, and transformed into Saccharomyces cerevisiae S288C for integration and expression.
1.1 Saccharomyces cerevisiae genomic DNA extraction
(1) Single colonies of yeast were picked from freshly grown YPD plates, inoculated into 100mL of liquid YPD medium, and cultured overnight at 30 ℃ and 150 rpm.
(2) Taking 4mL of bacterial liquid, centrifuging at 10000rpm for 1min, collecting yeast cells, washing with deionized water for 2 times, and removing impurities on the cell surfaces such as a culture medium.
(3) To the yeast cells, 500. mu.L of a lysis solution (2% Triton X-100, 0.1M Tris. HCl pH 8.0, 50mM EDTA, 2% SDS) was added, and the yeast cells were resuspended and transferred to a 1.5mL centrifuge tube.
(4) Approximately 500. mu.L of acid-washed glass beads 0.5mM in diameter were added, mixed with 25. mu.L of a 5mM NaCl solution, vortexed at high speed for 5min, and the cells were disrupted.
(5) The cell disruption solution was centrifuged at 12000rpm for 5min, and the supernatant was transferred to a clean 1.5mL centrifuge tube.
(6) Adding equal volume of phenol/chloroform/isoamyl alcohol (25:24:1) into the supernatant obtained after the centrifugation in the step (5), shaking and mixing uniformly, centrifuging at 12000rpm for 5min, and transferring the supernatant into a clean centrifuge tube.
(7) Adding 2 times volume of precooled absolute ethyl alcohol into the supernatant obtained after the centrifugation in the step (6), standing for 30min at the temperature of minus 80 ℃, precipitating the genome DNA, and centrifuging for 10min at the temperature of 4 ℃ and 12000 rpm.
(8) The supernatant was discarded, the pellet was washed with pre-cooled 70% ethanol 2 times, left at room temperature for 5min to volatilize ethanol, and the DNA pellet was dissolved in 50. mu.L of TE buffer.
(9) Add 1. mu.L 10mg/mL RNase A, incubate at 37 ℃ for 30min, digest RNA, store at-20 ℃.
1.2PCR amplification of the Gene band of interest
The gene YPL162C was amplified using the flocculated yeast SPSC01 DNA as a template. The primer sequences are as follows:
the PCR reaction was as follows (50. mu.L):
setting a PCR reaction program:
after the PCR was completed, the product was subjected to agarose gel electrophoresis to detect the fragment size, which was consistent with the sequence length in the NCBI database (FIG. 1).
1.3 cleavage of the target fragment
The PCR product was purified using a DNA purification kit and then cleaved with an enzyme. The enzyme digestion reaction system is as follows:
the reaction was incubated at 37 ℃ for 3 h.
And recovering the target DNA fragment by using a gel recovery kit, and freezing and storing at-20 ℃ for later use after detection.
1.4 connection of the Gene of interest to the vector (25. mu.L)
And connecting the prepared target fragment with the vector fragment after enzyme digestion and recovery.
The reaction system is as follows:
the reaction time was 10h in the ligator and the reaction temperature was 16 deg.C (see FIG. 2 for the constructed vector).
1.5 ligation product transformation of E.coli DH 5. alpha
1.5.1 preparation of competent cells of Escherichia coli
(1) Inoculating 200. mu.L of Escherichia coli DH5 stored at-80 deg.C into LB liquid culture medium, culturing at 37 deg.C and 200rpm overnight;
(2) transferring overnight cultured bacterial liquid into 50mL fresh LB liquid culture medium at a ratio of 1:100, culturing at 37 deg.C and 200rpm for 3-4h to OD600nmAbout 0.5;
(3) transferring the bacterial liquid into a 50mL centrifugal tube precooled on ice, placing the centrifugal tube on ice for 30min, and centrifuging the centrifugal tube at 4 ℃ and 4000rpm for 5 min;
(4) discarding the supernatant, using pre-cooled 0.1mol/L CaCl215mL of suspension cells are placed on ice for 30min, centrifuged at 4 ℃ and 4000rpm for 5min, and the supernatant is discarded;
(5) repeating the above steps;
(6) adding pre-cooled 0.1mol/L CaCl2Resuspend cells in 2mL of solution, add 2mL of pre-cooled 30% glycerol, mix gently, and split into 200. mu.L aliquots and freeze-store at-80 ℃.
1.5.2 transformation of ligation products
(1) Taking 200 μ L of competent cells from a refrigerator at-80 deg.C, and thawing on ice;
(2) adding 10 μ L of the ligation product into the competent cells, gently mixing with a pipette, and standing on ice for 30 min;
(3) placing the competent cells in a water bath kettle at 42 ℃ for 90s by heat shock, and then rapidly placing the competent cells in an ice bath for cooling for 2 min;
(4) adding 800 μ L LB liquid culture medium (without antibiotic) into the tube, mixing, and performing shaking culture at 37 deg.C for 1 h;
(5) centrifuging at 4000rpm for 5min, discarding part of the supernatant, mixing the rest solution, spreading on a screening plate containing corresponding antibiotics (final concentration of ampicillin is 100 μ g/mL), standing for half an hour with the front side facing upwards, air drying the bacteria solution completely, inverting the culture dish, and culturing at 37 deg.C for 12-16 h;
(6) and selecting positive colonies for identification.
1.5.3 transformant plasmid extraction
Transformant plasmids (E.Z.N.A Plasmid DNA MiNi Kit I Protocol-Spin Protocol) were extracted using an OMEG Plasmid extraction Kit.
1.5.4 PCR identification of Positive transformants
The extracted plasmid was used as a template for PCR reaction to verify the transformant. The target gene was amplified according to the method of 1.2 and verified by PCR.
After the PCR is finished, the product is subjected to agarose gel electrophoresis to detect whether the size of the gene fragment is correct or not.
1.6 linearization of recombinant plasmids
Since the recombinant plasmid needs to be linearized and then transferred into yeast for integration and expression, the plasmid is digested with Not I restriction enzyme. The enzyme digestion reaction system is as follows:
the reaction was incubated at 37 ℃ for 10 h.
And recovering the target DNA fragment by using a gel recovery kit, and freezing and storing at-20 ℃ for later use after detecting without errors.
Example 2: saccharomyces cerevisiae chemical transformation of unknown protein gene YPL162C
The saccharomyces cerevisiae cell chemical transformation method comprises the following steps:
(1) inoculating yeast strain S288C preserved at-80 deg.C into YPD culture medium, culturing at 30 deg.C and 150rpm for 12-14 hr, and inoculating into new YPD culture medium (1% inoculation) for 6 hr;
(2) centrifuging with a 50mL centrifuge tube to collect thalli, and centrifuging at 3000rpm for 3 min;
(3) discarding the supernatant, resuspending the cells with 20mL of sterile ultrapure water, and centrifuging at 3000rpm for 3 min;
(4) discarding the supernatant, resuspending the cells with 20mL of 0.1M LiAC (lithium acetate solution), and centrifuging at 3000rpm for 3 min;
(5) discard the supernatant, resuspend the cells with 0.5-2mL of 0.1M LiAC to OD620nm2.0-3.0;
(6) taking 100 mu L of the bacterial liquid into a 1.5mL centrifuge tube, and centrifuging for 3min at 3000 rpm;
(7) discarding the supernatant, adding 240 mu L of 50% PEG (average molecular weight 3350-4000), 36 mu L of 1M LiAC, 50 mu L of 2mg/mL single-stranded salmon sperm DNA and 1 mu g of DNA fragment into a centrifuge tube, and uniformly mixing;
(8) water bath at 42 ℃ for 40-60 min;
(9) centrifuging at 3000rpm for 3min, discarding supernatant, adding 800 μ L YPD medium, culturing at 30 deg.C and 150rpm for 1-2 hr;
(10) centrifuging at 3000rpm for 3min, discarding part of supernatant to obtain concentrated bacterial liquid, and coating on YPD plate containing G418 300 μ G/mL;
(11) the plates were placed upside down in an incubator at 30 ℃ until yeast transformant colonies grew.
(12) Single colonies with good growth status were randomly picked and inoculated into YPD liquid medium (containing 100. mu.g/mL of G418 antibiotic), a certain amount of cells were obtained and subjected to genomic DNA extraction (method same as 1.1), and a verification fragment (primers shown below) was amplified using the obtained genome as a template to verify (method same as 1.2) the integration of the target gene, the verification fragment comprising a part of the target gene YPL162C fragment and a part of the resistance gene fragment G418, and the total length was 1000 bp. And further verified by agarose gel electrophoresis (fig. 3).
The verification fragment primers were as follows:
example 3: expression of YPL162C gene in recombinant strain S288C-YPL162C and microscopic detection of cell growth morphology
3.1 expression of the recombinant YPL162C Gene
(1) Inoculating the recombinant unloaded yeast S288C-HO control strain and the recombinant saccharomyces cerevisiae S288C-YPL162C into 100mL of seed culture medium (30g/L glucose, 3g/L peptone, 4g/L yeast extract powder), culturing at 30 ℃ and 150rpm for 24 h;
(2) respectively taking bacterial liquid, measuring light absorption value at 620nm, and regulating OD with seed culture medium620To 1.5;
(3) inoculating 10% (v/v) of the culture medium (100g/L glucose, 3g/L peptone, 4g/L yeast extract powder, pH 4.5) to the fermentation medium, and culturing at 30 deg.C and 150 rpm;
(4) fermenting the strain to 12h (logarithmic phase), respectively taking 4mL of bacterial liquid, centrifuging, removing supernatant, washing cells for 2 times by using sterile water, quickly freezing thalli by using liquid nitrogen, preserving at-80 ℃, and extracting RNA for later use;
(5) extracting total RNA of recombinant bacteria S288C-YPL162C and control bacteria S288C-HO logarithmic growth phase by adopting a radix RNAsimple total RNA extraction kit;
(6) the extracted RNA is reversely transcribed into cDNA by referring to a TaKaRa PrimeScript TM RT reagent Kit with gDNA Eraser Kit method; Real-Time PCR referencePremix Ex TaqTM II kit method was performed, and the obtained data were analyzed for the relative expression amount of the gene.
As a result: the expression level of the recombinant strain S288C-YPL162C gene YPL162C was 2.4 times that of the control strain without adding any inhibitor. It was revealed that the desired gene YPL162C was overexpressed in the recombinant bacteria, and the results are shown in FIG. 4.
3.2 detection of cell growth morphology by recombinant Strain microscopy
(1) Inoculating recombinant unloaded yeast S288C-HO control strain and recombinant Saccharomyces cerevisiae S288C-YPL162C into 100mL seed culture medium (30g/L glucose, 3g/L peptone, 4g/L yeast extract), culturing at 30 deg.C and 150rpm to middle logarithmic phase (12 h);
(2) 1. mu.L of cells in the logarithmic growth phase of S288C-HO and S288C-YPL162C, respectively, were taken, and cell sections were prepared, observed with a microscope for cell morphology, and photographed.
As a result: as shown in FIG. 5, the S288C-HO control strain and the recombinant Saccharomyces cerevisiae S288C-YPL162C have no obvious difference in cell morphology observed under a microscope, which indicates that the cell morphology of the original strain is not affected after the YPL162C gene is over-expressed.
Example 4: comparison of growth of plates of recombinant Saccharomyces cerevisiae S288C-HO control strain and recombinant Saccharomyces cerevisiae S288C-YPL162C under different stress factors
(1) Inoculating the recombinant unloaded yeast S288C-HO control strain and the recombinant saccharomyces cerevisiae S288C-YPL162C into 100mL of seed culture medium (30g/L glucose, 3g/L peptone, 4g/L yeast extract powder), culturing at 30 ℃, 150rpm and over night;
(2) respectively inoculating overnight-cultured bacterial liquid into seed culture medium with an inoculum size of 10% (v/v) (same as step (1)), and culturing at 30 deg.C and 150rpm for 12 h;
(3) respectively taking bacterial liquid, measuring the light absorption value of the bacterial liquid at 620nm, and adjusting the OD value to 1.0 by using a sterilized seed culture medium;
(4) respectively carrying out 5-time gradient dilution on the bacterial liquid;
(5) sampling 2 μ L of the bacteria solution after gradient dilution in turn on YPD plates (20g/L glucose, 20g/L peptone, 10g/L yeast extract powder, 15g/L agar powder) containing 10g/L acetic acid, 1.5g/L furfural, 1g/L vanillin and no inhibitor;
(6) and (5) carrying out inverted culture in an incubator at 30 ℃, observing and comparing after bacterial colonies grow out, and photographing.
As a result: as seen from FIG. 6(a) control group, the growth status of the two strains S288C-HO and S288C-YPL162C were consistent under normal culture conditions (36 h of culture), indicating that YPL162C gene had no effect on the growth of the strains after overexpression.
As shown in FIG. 6(b), when 10g/L acetic acid was added to the medium (culture for 36 hours), the rest was addedUnder constant conditions, strain S288C-YPL162C was found to be 5-6The dilution gradient had colony growth, while the control strain S288C-HO was at 5-5The dilution gradient can not grow basically, which shows that the overexpression of the YPL162C gene improves the acetic acid tolerance of the recombinant strain S288C-YPL 162C.
Also as shown in FIGS. 6(c) and (b), when 1.5g/L furfural and 1g/L vanillin are added into the culture medium respectively, the growth state of the S288C-YPL162C strain in the solid culture medium is obviously better than that of the control strain S288C-HO, which indicates that the tolerance of the strain to furfural and vanillin is improved by over-expressing the YPL162C gene.
The plate growth experiments under different stress conditions show that after an unknown functional protein gene YPL162C is integrated and expressed on the chromosome of the saccharomyces cerevisiae S288C, the obtained saccharomyces cerevisiae strains S288C-YPL162C respectively have obviously enhanced tolerance to inhibitors of acetic acid, furfural and vanillin.
Example 5: comparison of ethanol fermentation conditions of recombinant Idle Yeast S288C-HO control Strain and recombinant Saccharomyces cerevisiae S288C-YPL162C with the addition of different inhibitors
(1) Respectively inoculating a control strain S288C-HO and a recombinant saccharomyces cerevisiae S288C-YPL162C into a 250mL shake flask containing 100mL of seed culture medium (30g/L glucose, 3g/L peptone and 4g/L yeast extract powder), and culturing at 30 ℃ and 150rpm for 24 h;
(2) respectively taking bacterial liquid, measuring the light absorption value of the bacterial liquid at 620nm, and then adjusting the OD to 1.5 by using a seed culture medium;
(3) the cells were inoculated into a fermentation medium containing 10g/L acetic acid, 2g/L vanillin and 3g/L furfural (100g/L glucose, 3g/L peptone, 4g/L yeast extract powder, pH 4.5) at an inoculum size of 10% (v/v), respectively, and subjected to ethanol fermentation at 30 ℃ and 150 rpm.
(4) Sampling at fixed time in the ethanol fermentation process of unloaded yeast S288C-HO and recombinant saccharomyces cerevisiae S288C-YPL162C, and respectively taking a certain amount of bacterial liquid to determine the density of the thallus by using an enzyme-linked immunosorbent assay to measure the light absorption value; and centrifuging the residual bacterial liquid, taking supernatant, detecting the concentration of residual glucose in the fermentation liquor by a DNS method, detecting the concentration of ethanol in the fermentation liquor by a gas chromatograph, and determining that the ethanol fermentation is finished when the concentration of the glucose in the supernatant is lower than 1 g/L.
As a result: as shown in FIG. 7(a), the over-expression strain S288C-YPL162C and the control strain S288C-HO enter the log phase at the same time in 12h with the progress of ethanol fermentation, the two strains reach the maximum value at the same time in 48h of fermentation, and the recombinant strain has a cell density 9% higher than that of the control strain. From FIG. 7(b), it is seen that the glucose consumption rate and ethanol production rate of the over-expressed strain S288C-YPL162C were both higher than those of the control strain S288C-HO. At 36h of fermentation, S288C-YPL162C had consumed all glucose, 12h earlier than the control strain S288C-HO. At 36h, the ethanol concentration of the recombinant strain reaches the maximum value of 37.3g/L, the ethanol concentration of the control strain reaches the maximum value of 36.8g/L at 48h, and the fermentation time is advanced by 12 h. The over-expression strain S288C-YPL162C is shown to have better growth state and fermentation performance than S288C-HO in a fermentation medium containing 10g/L of acetic acid, and the acetic acid tolerance of the strain is improved.
As seen from FIG. 8(a), during the ethanol fermentation process, the OD value of the over-expression strain S288C-YPL162C rapidly increased from 12h to 60h, and the cell density reached the maximum value 6h earlier than that of the control strain, and was increased by 71.4% compared with that of the control strain. As shown in FIG. 8(b), the glucose consumption rate and ethanol production rate of the over-expressed strain S288C-YPL162C were higher than those of the control strain S288C-HO, and the glucose consumption was completed and the ethanol concentration reached the maximum at 36h, which was 44h earlier than that of the control strain. The growth state and fermentation performance of the recombinant saccharomyces cerevisiae S288C-YPL162C with the over-expression gene YPL162C in a fermentation medium containing 2g/L of vanillin are obviously superior to those of S288C-HO, and the tolerance of the strain to the vanillin is enhanced.
As seen from FIG. 9(a), S288C-YPL162C entered the logarithmic phase 30h earlier than the control strain, and the maximum cell density was increased by 52% as compared with the control strain. As shown in FIG. 9(b), the strain S288C-YPL162C entered the rapid glucose consumption stage from 12 hours and consumed glucose 44 hours earlier than the control strain. The strain S288C-YPL162C has ethanol concentration up to 36g/L in 42h, the maximum ethanol concentration is increased by 24% compared with that of a control bacterium, and the fermentation time is shortened by 38 h. Therefore, the growth state and fermentation performance of the recombinant strain S288C-YPL162C in 3g/L furfural fermentation are obviously superior to those of a control strain, and the furfural tolerance of the original strain is obviously improved.
Claims (5)
1. A recombinant saccharomyces cerevisiae with acetic acid, furfural and vanillin tolerance is characterized by being named as S288C-YPL162C, having a preservation number of CGMCC No.13925, being preserved in the China general microbiological culture Collection center of China Committee for culture Collection of microorganisms, and having a preservation date of 2017, 03 and 23 days; the recombinant saccharomyces cerevisiae carries YPL162C gene, and the GenBank accession number of the gene is NM-001183976.1.
2. A method for constructing the recombinant Saccharomyces cerevisiae having acetic acid, furfural and vanillin tolerance of claim 1, comprising the steps of: the YPL162C gene obtained by PCR amplification is connected to a pHO constitutive integration expression vector by taking a self-flocculating yeast SPSC01 genome as a template, and is transferred into saccharomyces cerevisiae S288C after linearization to realize integration expression.
3. A method for constructing recombinant Saccharomyces cerevisiae having acetic acid, furfural and vanillin tolerance according to claim 1, comprising the steps of:
s1 construction and transformation of recombinant Saccharomyces cerevisiae containing YPL162C gene;
s1.1, extracting Saccharomyces cerevisiae genome DNA;
S1.2PCR amplifying target gene band;
s1.3, enzyme digestion of a target fragment;
s1.4 connecting the target gene with a vector;
s1.5 the ligation product is transformed into Escherichia coli DH5 alpha;
s1.6 linearization of recombinant plasmid;
and (3) obtaining a transformant by a S2 saccharomyces cerevisiae chemical transformation method.
4. The use of the recombinant Saccharomyces cerevisiae having acetic acid, furfural, and vanillin tolerance of claim 1 under inhibitor stress conditions.
5. The use of claim 4, wherein the inhibitor stress condition is a high concentration of acetic acid, a high concentration of furfural or a high concentration of vanillin.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711229127.0A CN107937296B (en) | 2017-11-29 | 2017-11-29 | Recombinant saccharomyces cerevisiae with acetic acid, furfural and vanillin tolerance, and preparation method and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711229127.0A CN107937296B (en) | 2017-11-29 | 2017-11-29 | Recombinant saccharomyces cerevisiae with acetic acid, furfural and vanillin tolerance, and preparation method and application thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN107937296A CN107937296A (en) | 2018-04-20 |
CN107937296B true CN107937296B (en) | 2020-12-11 |
Family
ID=61946733
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201711229127.0A Active CN107937296B (en) | 2017-11-29 | 2017-11-29 | Recombinant saccharomyces cerevisiae with acetic acid, furfural and vanillin tolerance, and preparation method and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107937296B (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110452827B (en) * | 2019-07-24 | 2020-07-31 | 中溶科技股份有限公司 | Gene recombination saccharomyces cerevisiae with detoxification function, construction method and application thereof |
CN111100801B (en) * | 2019-09-09 | 2024-02-23 | 四川农业大学 | Furfural inhibitor tolerant yeast engineering strain, construction method and application thereof |
CN112921049B (en) * | 2021-02-06 | 2024-01-23 | 石河子大学 | Gene segment for producing vanillin, saccharomyces cerevisiae engineering bacteria and construction method thereof |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007099451A1 (en) * | 2006-02-28 | 2007-09-07 | Suntory Limited | Method for identifying useful proteins of brewery yeast |
CN101880636A (en) * | 2010-06-04 | 2010-11-10 | 天津大学 | Bacterial strain tolerant with various inhibitors of Saccharomyces cerevisiae |
CN102947440A (en) * | 2009-12-30 | 2013-02-27 | 埃欧金能源公司 | Modified yeast strains exhibiting enhanced fermentation of lignocellulosic hydrolysates |
CN105154348A (en) * | 2015-08-05 | 2015-12-16 | 大连理工大学 | Method for improving tolerance of brewer's yeast to cellulose hydrolysate inhibitors |
-
2017
- 2017-11-29 CN CN201711229127.0A patent/CN107937296B/en active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007099451A1 (en) * | 2006-02-28 | 2007-09-07 | Suntory Limited | Method for identifying useful proteins of brewery yeast |
CN102947440A (en) * | 2009-12-30 | 2013-02-27 | 埃欧金能源公司 | Modified yeast strains exhibiting enhanced fermentation of lignocellulosic hydrolysates |
CN101880636A (en) * | 2010-06-04 | 2010-11-10 | 天津大学 | Bacterial strain tolerant with various inhibitors of Saccharomyces cerevisiae |
CN105154348A (en) * | 2015-08-05 | 2015-12-16 | 大连理工大学 | Method for improving tolerance of brewer's yeast to cellulose hydrolysate inhibitors |
Non-Patent Citations (4)
Title |
---|
Omics analysis of acetic acid tolerance in Saccharomyces cerevisiae;Peng Geng等;《World J Microbiol Biotechno》;20170412;第33卷;全文 * |
Rck2 Is Required for Reprogramming of Ribosomes during Oxidative StressD;Swarna Swaminathan等;《Mol Biol Cel》;20060331;第17卷(第3期);第1472页左栏最后1段至第1481页左栏倒数第2段,表1-2 * |
絮凝酵母SPSC01 连续培养最适生长条件的研究;王江龙等;《微生物学报》;20040204;第1卷;全文 * |
酿酒酵母乙酸耐性分子机制的功能基因组进展;赵心清等;《生物工程学报》;20140325;第30卷(第3期);全文 * |
Also Published As
Publication number | Publication date |
---|---|
CN107937296A (en) | 2018-04-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105199976B (en) | Recombinant saccharomyces cerevisiae strain for co-fermenting glucose and xylose and application thereof | |
CN107937297B (en) | Multi-inhibitor stress tolerance saccharomyces cerevisiae, and preparation method and application thereof | |
CN107937296B (en) | Recombinant saccharomyces cerevisiae with acetic acid, furfural and vanillin tolerance, and preparation method and application thereof | |
CN113717873B (en) | Multiple-tolerance saccharomyces cerevisiae strain and construction method and application thereof | |
CN115806922B (en) | Genetically engineered strain of zymomonas mobilis and application thereof | |
CN113881586B (en) | High-temperature-resistant, high-sugar-resistant and high-salt-resistant saccharomyces cerevisiae strain as well as construction method and application thereof | |
CN106995817B (en) | Construction of high concentration CO resistance by using gene of coding chloroplast carbonic anhydrase2Application of industrial engineering microalgae capable of rapidly growing | |
Weusthuis et al. | Monascus ruber as cell factory for lactic acid production at low pH | |
CN103849576A (en) | Recombined saccharomyces cerevisiae strain with stress tolerance | |
CN114277042A (en) | Rhodosporidium toruloides recombinant expression strain for high-yield ergothioneine and construction method and application thereof | |
Hermansyah et al. | Candida tropicalis isolated from Tuak, a North Sumatera-Indonesian traditional beverage, for bioethanol production | |
CN105368731B (en) | Saccharomyces cerevisiae strain for expressing xylose isomerase and construction method thereof | |
CN107974453B (en) | Method for improving cell activity and multiple stress resistance of saccharomyces cerevisiae and application | |
WO2020134427A1 (en) | Use of sll0528 gene in improving ethanol tolerance of synechocystis sp. pcc 6803 | |
CN115948450B (en) | Chlamydomonas reinhardtii chloroplast-saccharomyces cerevisiae-escherichia coli shuttle vector and construction method and application thereof | |
ES2912995T3 (en) | Obtaining high-yield yeast strains for arabinose metabolization | |
CN104152482A (en) | RecET recombination system expression plasmids for zymomonas mobilis, as well as construction method and applications thereof | |
CN109536397B (en) | Genetic engineering saccharomyces cerevisiae and preparation method and application thereof | |
CN101892250A (en) | Method for constructing cryptococcus albidus engineering bacterial strain for producing oleic acid in high yield | |
CN101525580B (en) | Amphiploid histidine auxotroph saccharomyces cerevisiae and constructing method thereof | |
CN101696418B (en) | Construction method of plasmid taking yeast G418 as selective marker | |
CN105087631A (en) | Method for improving absorption and utilization capacities of brewer's yeast xylose | |
CN110551702A (en) | Recombinant aspergillus tubingensis tannase and expression and application thereof | |
CN110904123B (en) | Strain for promoting high-yield cane molasses alcohol fermentation and application thereof | |
CN114015634B (en) | Recombinant escherichia coli for high yield of succinic acid and construction method and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |